Trau group researchers are using nanotechnology for fabrication-free disease biomarker detection within a fluidic droplet. The “lab-in-a-drop” system can be extremely useful for the detection of disease nucleic acid biomarkers.
The Wolvetang laboratory at AIBN recently found that key areas of the brain affected in this disease can be recreated in the lab using patient-derived stem cells, and this has now been published in the journal Frontiers in Cellular Neuroscience.
Associate Professor Jessica Mar has received a $50,000 Metcalf Prize from the National Stem Cell Foundation of Australia in recognition of her leadership in stem cell research.
